TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT04568161 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03226236 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02529813 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04391738 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01208441 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05635539 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05635539 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00005780 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00005780 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00334724 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04785235 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04785235 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT04785235 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03437278 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT00360256 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01477333 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT02845323 — Predictive Biomarker (PRD): TNFRSF9 mRNA
Genes: TNFRSF9; CD137; ILA
Study NCT06722599 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03840239 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT04021602 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00555178 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03554954 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03861377 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04467736 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01142778 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01142778 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01110876 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01110876 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01813708 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00093834 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03538470 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01229930 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT03931720 — Predictive Biomarker (PRD): ROBO1 mRNA
Genes: ROBO1; DUTT1
Study NCT01379391 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01379391 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT00759291 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00406653 — Predictive Biomarker (PRD): CTLA4
Genes: CD152; CD; GSE; CTLA-4
Study NCT01005433 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02920333 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT00200460 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03194100 — Predictive Biomarker (PRD): METRNL mRNA
Genes: METRNL
Study NCT03994705 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT03707938 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT00101920 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00101920 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01640275 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05350579 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00001563 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT02425930 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT00200434 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01498289 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study NCT02341326 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT01667523 — Predictive Biomarker (PRD): TRPV1 mRNA
Genes: TRPV1; VR1
Study NCT01667523 — Predictive Biomarker (PRD): TRPA1 mRNA
Genes: TRPA1; ANKTM1
Study NCT01779687 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01779687 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT04532268 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00939679 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT00939679 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT03555474 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT02471651 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02471651 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01288573 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01288573 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT01500590 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT01961765 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT01961765 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05146687 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05146687 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05146687 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00500617 — Predictive Biomarker (PRD): CALD1 mRNA
Genes: CALD1; CAD; CDM
Study NCT01647789 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CYP17A1 mRNA
Genes: CYP17A1; CYP17; S17AH
Study NCT04499274 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT06288490 — Surrogate Endpoint (SUR): Serum calcium
Study NCT05632055 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT01258335 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03407794 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00002649 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04017221 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04017221 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00516243 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00012298 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00012298 — Predictive Biomarker (PRD): IL11
Genes: IL-11; AGIF
Study NCT00683462 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03591302 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00409773 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00409773 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT00772226 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00448409 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00117845 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00117845 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT00117845 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02972463 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01836653 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03083899 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03860584 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT03860584 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00221182 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02772341 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02244385 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02804776 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02804776 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04983628 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04983628 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT04983628 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT00882440 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02865616 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT00502892 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03668353 — Predictive Biomarker (PRD): FGF2 mRNA
Genes: FGF2; FGFB
Study NCT03668353 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03668353 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT04446325 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT00001407 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02715154 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02046395 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00615329 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT03969550 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT03168789 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00681044 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02158520 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02158520 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT02158520 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01749605 — Predictive Biomarker (PRD): UBC mRNA
Genes: UBC
Study NCT00001353 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01256411 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00992433 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04355481 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02824042 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04604600 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT03514823 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05411562 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03806387 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study NCT00629330 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT02261597 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01130584 — Predictive Biomarker (PRD): PKM mRNA
Genes: PKM; OIP3; PK2; PK3; PKM2
Study NCT01240668 — Surrogate Endpoint (SUR): Serum sodium
Study NCT02418273 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02462564 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03285178 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT01642173 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study NCT01620866 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05138367 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04684628 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01871311 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01871311 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT04386707 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01762033 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01762033 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02446886 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT01298362 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01298362 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00070070 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02917278 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02917278 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02917278 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02917278 — Surrogate Endpoint (SUR): Serum calcium
Study NCT02917278 — Surrogate Endpoint (SUR): Serum sodium
Study NCT02917278 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT02917278 — Surrogate Endpoint (SUR): Serum phosphate
Study NCT00630721 — Predictive Biomarker (PRD): SOCS3 mRNA
Genes: SOCS3; CIS3; SSI3
Study NCT04525066 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03986788 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01800214 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT02963181 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04239040 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03519074 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT03984799 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT04526197 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT03499197 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAV1 mRNA
Genes: CAV1; CAV
Study NCT00381303 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04184193 — Predictive Biomarker (PRD): TSC2
Genes: tuberin; LAM; PPP1R160
Study NCT03728374 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03728374 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT00005801 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00364026 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01594008 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01749449 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT04137900 — Predictive Biomarker (PRD): BTLA mRNA
Genes: BTLA
Study NCT04137900 — Predictive Biomarker (PRD): TNFRSF14 mRNA
Genes: TNFRSF14; HVEA; HVEM; UNQ329/PRO509
Study NCT03853226 — Predictive Biomarker (PRD): GLA
Genes: GALA
Study NCT00499629 — Predictive Biomarker (PRD): NR1H4 mRNA
Genes: NR1H4; BAR; FXR; HRR1; RIP14
Study NCT03099200 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00392405 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00392405 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03321487 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT02660489 — Predictive Biomarker (PRD): PTGDR2 mRNA
Genes: PTGDR2; CRTH2; DL1R; GPR44
Study NCT02882087 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05338723 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00001962 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05049408 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study NCT05049408 — Monitoring Biomarker (MOI): Matrix metalloproteinase 1
Genes: MMP1; CLG
Study NCT03551574 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT05638399 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04237467 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04389294 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04058613 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02673151 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04023721 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00133692 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00133692 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02945579 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01320189 — Predictive Biomarker (PRD): FTO mRNA
Genes: FTO; KIAA1752
Study NCT02451241 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00534573 — Safety Biomarker (SAF): DRD3
Study NCT04190420 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01954381 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01954381 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03509233 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT03735537 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01570426 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT03207464 — Predictive Biomarker (PRD): NE
Study NCT02430974 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02430974 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01761461 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT00707252 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03257566 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT00981981 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT00981981 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01108250 — Predictive Biomarker (PRD): HTRA1 mRNA
Genes: HTRA1; HTRA; PRSS11
Study NCT04780295 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04961710 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT02784483 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT01351909 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01351909 — Predictive Biomarker (PRD): PARP1 mRNA
Genes: PARP1; ADPRT; PPOL
Study NCT03105531 — Surrogate Endpoint (SUR): Serum potassium
Study NCT01939054 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01939054 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03585595 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01637623 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02930356 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT02397954 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT02397954 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02397954 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02799953 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02092779 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT00679653 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02695641 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02695641 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00524901 — Predictive Biomarker (PRD): EPOR mRNA
Genes: EPOR
Study NCT00524901 — Predictive Biomarker (PRD): STAT5A mRNA
Genes: STAT5A; STAT5
Study NCT00524901 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT00454389 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03717948 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study NCT00287105 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00287105 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT02851082 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT02555540 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01216033 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00442169 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00141726 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04380662 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03758287 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01866618 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study NCT02267616 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study NCT04223869 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT02262923 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02262923 — Safety Biomarker (SAF): DRD2
Study NCT02262923 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03235505 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT02489903 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01610427 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02250105 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00133146 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study NCT02803892 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01553708 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04859959 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT01924845 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT00882804 — Monitoring Biomarker (MOI): Heme oxygenase 1
Genes: HMOX1; HO; HO1